Last reviewed · How we verify

NCT02883634

Specific or Non-Specific Manipulation for Patients With Back Pain

Completed NA Last updated 26 September 2019
What this trial tests

NA trial testing Specific manipulation in Low Back Pain in 148 participants. Completed in 23 November 2018.

Timeline
3 April 2017
Primary endpoint
23 November 2018
23 November 2018

Quick facts

Lead sponsorUniversidade Cidade de Sao Paulo
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment148
Start date3 April 2017
Primary completion23 November 2018
Estimated completion23 November 2018
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

Universidade Cidade de Sao Paulo

Who can join

Adults 18 to 80, any sex, with Low Back Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

We aim to evaluate the long-term effects of 10 sessions of spinal manipulative therapy applied in a vertebral region-specific or region nonspecific level immediately after treatment and 3 and 6 months after randomization.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Directed vertebral manipulation is not better than generic vertebral manipulation in patients with chronic low back pain: a randomised trial.
    de Oliveira RF, Costa LOP, Nascimento LP, Rissato LL. · · 2020 · cited 19× · PMID 32660919 · DOI 10.1016/j.jphys.2020.06.007

Verify or expand the search:

Other recruiting trials for Low Back Pain

Currently open trials in the same condition.

Other Universidade Cidade de Sao Paulo trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02883634.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing